WebNov 14, 2024 · EpiEndo is a clinical-stage biopharmaceutical company with a unique approach to inflammatory disorders that focuses on enhancement of epithelial barrier integrity as a critical pathophysiological... WebMar 24, 2024 · REYKJAVIK, Iceland--(BUSINESS WIRE)-- EpiEndo Pharmaceuticals is pleased to announce the appointment of Stefan Petursson as Chief Financial Officer (CFO), starting 1 April 2024.EpiEndo Pharmaceuticals is a privately held biopharmaceutical company developing a therapeutic pipeline for the treatment of inflammatory disorders …
EpiEndo Pharmaceuticals wins the Swedish American Life ... - BioSpace
WebHome EpiEndo Pharmaceuticals A NOVEL APPROACH TO AIRWAY DISEASES Find out more about our unique therapeutic strategy Our non-antibiotic macrolide platform … Welcome to EpiEndo Pharmaceuticals. EpiEndo is a clinical stage … EpiEndo's compounds enhance the epithelial barrier, appearing to … EpiEndo’s lead compounds are analogues of azithromycin, specifically designed to … OUR NEWS & EVENTS. Feb 15; Dr Kate Hanrott appointed as Director of Clinical … WebAug 18, 2024 · EpiEndo is a clinical-stage biopharmaceutical company with a unique approach to inflammatory disorders that focuses on enhancement of epithelial barrier … soho homes new york
EpiEndo Pharmaceuticals Expands its Leadership Team, …
WebNov 15, 2024 · Labiotech.eu covers the global biotech industry, read by 150,000+ monthly visitors. Hope you'll enjoy our Biotech News! WebJun 29, 2024 · In August 2024, EpiEndo Pharmaceuticals announced the closing of a €20m Series A financing round led by Flerie Invest and Iðunn Venture Fund, with existing investors ABC Ventures participating,... WebApr 13, 2024 · EpiEndo is a clinical-stage biopharmaceutical company with a unique approach to inflammatory disorders that focuses on the enhancement of epithelial barrier … slq camp humphreys